Inari Medical ticks higher after HSR waiting period expires in Stryker deal
Penumbra spikes after Stryker- Inari deal
Stryker confirms deal to purchase Inari Medical for $80 a share
Inari Medical soars on report of Stryker talks
Stryker to buy pain therapy developer Vertos Medical
144.57BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8636671013
CUSIP
863667101
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
50.51
PEG Ratio
2.18
Book Value
54.77
Dividend Share
3.28
Dividend Yield
0.90%
Earnings Share
7.39
Wall Street Target Price
421.46
EPS Estimate Current Year
13.34
EPS Estimate Next Year
14.81
EPS Estimate Current Quarter
2.7301
EPS Estimate Next Quarter
3.1427
Most Recent Quarter
-
Revenue TTM
23,217,999,872
Gross Profit TTM
15,022,000,128
EBITDA
6,176,999,936
Profit Margin
12.31%
Return On Assets TTM
7.49%
Return On Equity TTM
14.26%
Revenue Per Share TTM
60.888
Qtly Revenue Growth YOY
11.90%
Diluted Eps TTM
7.39
Qtly Earnings Growth YOY
-17.60%
Trailing PE
50.51
Forward PE
28
Price Sales TTM
6.1456
Price Book MRQ
6.8154
Enterprise Value Revenue
6
Enterprise Value EBITDA
27
73.98
0.94%132.50
0.15%23.21
0.00%301.00
-1.13%81.03
-0.95%85.81
-0.47%26.06
-0.44%236.23
-0.40%101.42
-0.30%53.24
-0.12%Curated watchlists where SYK is featured.